ClariVest Asset Management’s Lineage Cell Therapeutics LCTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-64,467
| Closed | -$150K | – | 748 |
|
|
2018
Q1 | $150K | Buy |
64,467
+6,265
| +11% | +$14.6K | ﹤0.01% | 631 |
|
|
2017
Q4 | $110K | Hold |
58,202
| – | – | ﹤0.01% | 624 |
|
|
2017
Q3 | $145K | Buy |
58,202
+2,258
| +4% | +$5.63K | ﹤0.01% | 520 |
|
|
2017
Q2 | $153K | Hold |
55,944
| – | – | ﹤0.01% | 503 |
|
|
2017
Q1 | $169K | Buy |
+55,944
| New | +$169K | ﹤0.01% | 504 |
|